Drug Type Small molecule drug |
Synonyms NIC 0102, NIC-0102, NIC0102 |
Target |
Action inhibitors |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC21H25BF2N2O4 |
InChIKeyQTRFWSIBLJYXFJ-ROUUACIJSA-N |
CAS Registry2806031-94-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Discovery | China | 05 Sep 2022 |